NTP‐CERHR Expert Panel Report on the reproductive and developmental toxicity of styrene
2005; Wiley; Volume: 77; Issue: 2 Linguagem: Inglês
10.1002/bdrb.20061
ISSN2472-1727
AutoresUlrike Luderer, T.F.X. Collins, George P. Daston, Lawrence J. Fischer, Ronald H. Gray, Franklin E. Mirer, Andrew F. Olshan, R. Woodrow Setzer, Kimberley A. Treinen, Roel Vermeulen,
Tópico(s)Carcinogens and Genotoxicity Assessment
ResumoBirth Defects Research Part B: Developmental and Reproductive ToxicologyVolume 77, Issue 2 p. 110-193 Expert Panel Report NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of styrene†‡§¶‖ Ulrike Luderer, Ulrike Luderer [email protected] University of California-Irvine, Irvine, CASearch for more papers by this authorThomas F.X. Collins, Thomas F.X. Collins U.S. Food and Drug Administration, Laurel, MDSearch for more papers by this authorGeorge P. Daston, George P. Daston The Procter & Gamble Company, Cinncinati, OHSearch for more papers by this authorLawrence J. Fischer, Lawrence J. Fischer Michigan State University, East Lansing, MISearch for more papers by this authorRonald H. Gray, Ronald H. Gray Johns Hopkins University, Baltimore, MDSearch for more papers by this authorFranklin E. Mirer, Franklin E. Mirer International Union, United Auto Workers, Detroit, MISearch for more papers by this authorAndrew F. Olshan, Andrew F. Olshan University of North Carolina, Chapel Hill, CASearch for more papers by this authorR. Woodrow Setzer, R. Woodrow Setzer U.S. Environmental Protection Agency, Research Triangle Park, NCSearch for more papers by this authorKimberley A. Treinen, Kimberley A. Treinen Schering-Plough Research Institute, Lafayette, NJSearch for more papers by this authorRoel Vermeulen, Roel Vermeulen National Cancer Institute, Bethesda, MDSearch for more papers by this author Ulrike Luderer, Ulrike Luderer [email protected] University of California-Irvine, Irvine, CASearch for more papers by this authorThomas F.X. Collins, Thomas F.X. Collins U.S. Food and Drug Administration, Laurel, MDSearch for more papers by this authorGeorge P. Daston, George P. Daston The Procter & Gamble Company, Cinncinati, OHSearch for more papers by this authorLawrence J. Fischer, Lawrence J. Fischer Michigan State University, East Lansing, MISearch for more papers by this authorRonald H. Gray, Ronald H. Gray Johns Hopkins University, Baltimore, MDSearch for more papers by this authorFranklin E. Mirer, Franklin E. Mirer International Union, United Auto Workers, Detroit, MISearch for more papers by this authorAndrew F. Olshan, Andrew F. Olshan University of North Carolina, Chapel Hill, CASearch for more papers by this authorR. Woodrow Setzer, R. Woodrow Setzer U.S. Environmental Protection Agency, Research Triangle Park, NCSearch for more papers by this authorKimberley A. Treinen, Kimberley A. Treinen Schering-Plough Research Institute, Lafayette, NJSearch for more papers by this authorRoel Vermeulen, Roel Vermeulen National Cancer Institute, Bethesda, MDSearch for more papers by this author First published: 12 December 2005 https://doi.org/10.1002/bdrb.20061Citations: 5 † This article is a U.S. Government work and, as such, is in the public domain in the United States of America. ‡ A report of the CERHR Expert Panel with the support of CERHR Staff: NTP/NIEHS, Michael Shelby, Ph.D. (Director, CERHR), Christopher Portier, Ph.D. (Associate Director, National Toxicology Program); Sciences International, Inc., Anthony Scialli, M.D. (Principal Scientist), Annette Iannucci, M.S. (Toxicologist), Gloria Jahnke, D.V.M. (Toxicologist), Jessie Poulin, (Analyst). § This report is prepared according to the Guidelines for CERHR Panel Members established by NTP/NIEHS. The guidelines are available from the CERHR web site (http://cerhr.niehs.nih.gov/). The format for Expert Panel Reports includes synopses of studies reviewed, followed by an evaluation of the Strengths/Weaknesses and Utility (Adequacy) of the study for a CERHR evaluation. Statements and conclusions made under Strengths/Weaknesses and Utility evaluations are those of the Expert Panel and are prepared according to the NTP/NIEHS guidelines. In addition, the Panel often makes comments or notes limitations in the synopses of the study. Bold, square brackets are used to enclose such statements. As discussed in the guidelines, square brackets are used to enclose key items of information not provided in a publication, limitations noted in the study, conclusions that differ from authors, and conversions or analyses of data conducted by the Panel. ¶ The findings and conclusions of this report are those of the Expert Panel and should not be construed to represent the views of the National Toxicology Program.: ‖ Michael D. Shelby, PhD, NIEHS EC-32, PO Box 12233, Research Triangle Park, NC 27709. E-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References ACGIH. 2003. Styrene. TLVs and BEIs based on the documentation of the threshold limit values and biological exposure indices. Ahlborg Jr G, Bjerkedal T, Egenaes J. 1987. Delivery outcome among women employed in the plastics industry in Sweden and Norway. Am J Ind Med 12: 507–517. Alexander M. 1997. Environmental fate and effects of styrene. Crit Rev Environ Sci Technol 27: 383–410. Anzenbacher P, Anzenbacherova E. 2001. Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 58: 737–747. Arfini G, Mutti A, Vescovi P, Ferroni C, Ferrari M, Giaroli C, Passeri M, Franchini I. 1987. Impaired dopaminergic modulation of pituitary secretion in work occupationally exposed to styrene: further evidence from PRL response to TRH stimulation. J Occup Med 129: 826–830. ATSDR. 1992. Toxicological profile for styrene. Available at http://www.atsdr.cdc.gov/toxprofiles/tp53.html. Atlanta, GA: Agency for Toxic Substances and Disease Registry. Beliles RP, Butala JH, Stack CR, Makris S. 1985. Chronic toxicity and three-generation reproduction study of styrene monomer in the drinking water of rats. Fundam Appl Toxicol 5: 855–868. Benignus VA, Geller AM, Boyes WK, Bushnell PJ. 2005. Human neurobehavioral effects of long-term exposure to styrene: a meta-analysis. Environ Health Perspect 113: 532–538. Bergamaschi E, Mutti A, Cavazzini S, Vettori MV, Renzulli FS, Franchini I. 1996. Peripheral markers of neurochemical effects among styrene-exposed workers. Neurotoxicology 17: 753–759. Bergamaschi E, Smargiassi A, Mutti A, Cavazzini S, Vettori MV, Alinovi R, Franchini I, Mergler D. 1997. Peripheral markers of catecholaminergic dysfunction and symptoms of neurotoxicity among styrene-exposed workers. Int Arch Occup Environ Health 69: 209–214. Bonde JP, Joffe M, Danscher G, Apostoli P, Bisanti L, Giwercman A, Kolstad HA, Thonneau P, Roeleveld N, Vanhoorne M. 1999. Objectives, designs and populations of the European Asclepios study on occupational hazards to male reproductive capability. Scand J Work Environ Health 25(Suppl): 49–61; discussion 76–48. Brown NA. 1991. Reproductive and developmental toxicity of styrene. Reprod Toxicol 5: 3–29. Brown NA, Lamb JC, Brown SM, Neal BH. 2000. A review of the developmental and reproductive toxicity of styrene. Regul Toxicol Pharmacol 32: 228–247. Brown-Woodman PD, Webster WS, Picker K, Huq F. 1994. In vitro assessment of individual and interactive effects of aromatic hydrocarbons on embryonic development of the rat. Reprod Toxicol 8: 121–135. Brunnemann KD, Rivenson A, Cheng SC, Saa V, Hoffmann D. 1992. A study of tobacco carcinogenesis. XLVII. Bioassays of vinylpyridines for genotoxicity and for tumorigenicity in A/J mice. Cancer Lett 65: 107–113. Chakrabarti SK. 2000. Altered regulation of dopaminergic activity and impairment in motor function in rats after subchronic exposure to styrene. Pharmacol Biochem Behav 66: 523–532. ChemIDplus. 2004. Styrene. Available at http://chem.sis.nlm.nih.gov/chemidplus/jsp/chemidlite/ChemFull.jsp. National Library of Medicine. Chernoff N, Setzer RW, Miller DB, Rosen MB, Rogers JM. 1990. Effects of chemically induced maternal toxicity on prenatal development in the rat. Teratology 42: 651–658. Cho SI, Damokosh AI, Ryan LM, Chen D, Hu YA, Smith TJ, Christiani DC, Xu X. 2001. Effects of exposure to organic solvents on menstrual cycle length. J Occup Environ Med 43: 567–575. Cohen JT, Carlson G, Charnley G, Coggon D, Delzell E, Graham JD, Greim H, Krewski D, Medinsky M, Monson R, Paustenbach D, Petersen B, Rappaport S, Rhomberg L, Ryan PB, Thompson K. 2002. A comprehensive evaluation of the potential health risks associated with occupational and environmental exposure to styrene. J Toxicol Environ Health B Crit Rev 5: 1–265. Conti B, Maltoni C, Perino G, Ciliberti A. 1988. Long-term carcinogenicity bioassays on styrene administered by inhalation, ingestion and injection and styrene oxide administered by ingestion in Sprague-Dawley rats, and para-methylstyrene administered by ingestion in Sprague-Dawley rats and Swiss mice. Ann NY Acad Sci 534: 203–234. Cruzan G, Carlson GP, Johnson KA, Andrews LS, Banton MI, Bevan C, Cushman JR. 2002. Styrene respiratory tract toxicity and mouse lung tumors are mediated by CYP2F-generated metabolites. Regul Toxicol Pharmacol 35: 308–319. Cruzan G, Carlson GP, Turner M, Mellert W. 2005a. Ring-oxidized metabolites of styrene contribute to styrene-induced Clara-cell toxicity in mice. J Toxicol Environ Health A 68: 229–237. Cruzan G, Cushman JR, Andrews LS, Granville GC, Johnson KA, Bevan C, Hardy CJ, Coombs DW, Mullins PA, Brown WR. 2001. Chronic toxicity/oncogenicity study of styrene in CD-1 mice by inhalation exposure for 104 weeks. J Appl Toxicol 21: 185–198. Cruzan G, Cushman JR, Andrews LS, Granville GC, Johnson KA, Hardy CJ, Coombs DW, Mullins PA, Brown WR. 1998. Chronic toxicity/oncogenicity study of styrene in CD rats by inhalation exposure for 104 weeks. Toxicol Sci 46: 266–281. Cruzan G, Cushman JR, Andrews LS, Granville GC, Miller RR, Hardy CJ, Coombs DW, Mullins PA. 1997. Subchronic inhalation studies of styrene in CD rats and CD-1 mice. Fundam Appl Toxicol 35: 152–165. Cruzan G, Faber WD, Johnson KA, Roberts LS, Hellwig J, Carney E, Yarrington JT, Stump DG. 2005b. Two generation reproductive study of styrene by inhalation in Crl-CD rats. Birth Defects Res (Part B) 74: 211–220. Cruzan G, Faber WD, Johnson KA, Roberts LS, Maurissen J, Beck MJ, Radovsky A, Stump DG, Buelke-Sam J. 2005c. Developmental neurotoxicity study of styrene by inhalation in Crl-CD rats. Birth Defects Res (Part B) 74: 221–232. Daston GP, Overmann GJ, Taubeneck MW, Lehman-McKeeman LD, Rogers JM, Keen CL. 1991. The role of metallothionein induction and altered zinc status in maternally mediated developmental toxicity: comparison of the effects of urethane and styrene in rats. Toxicol Appl Pharmacol 110: 450–463. Date K, Ohno K, Azuma Y, Hirano S, Kobayashi K, Sakurai T, Nobuhara Y, Yamada T. 2002. Endocrine-disrupting effects of styrene oligomers that migrated from polystyrene containers into food. Food Chem Toxicol 40: 65–75. Eriksson K, Wiklund L. 2004. Dermal exposure to styrene in the fiberglass reinforced plastics industry. Ann Occup Hyg 48: 203–208. EU. 2002. Risk assessment report-styrene-part I-environment. Available at http://ecb.jrc.it/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/REPORT/styrenereport034.pdf. European Union. Report nr EUR 20541 EN. Fabry L, Léonard A, Roberfroid M. 1978. Mutagenicity tests with styrene oxide in mammals. Mutat Res 51: 377–381. FDA. 2003. Food and Drug Administration Total Diet Study—summary of residues found ordered by pesticides—market baskets 91-3—01-4. Available at http://www.cfsan.fda.gov/∼acrobat/TDS1byps.pdf. Food and Drug Administration. FDA. 2004. Code of federal regulations (CFR): GPO access. Available at http://www.gpoaccess.gov/cfr/index.html. Fishbein L. 1992. Exposure from occupational versus other sources. Scand J Work Environ Health 18(Suppl): 5–16. Fisher J, Mahle D, Bankston L, Greene R, Gerhart J. 1997. Lactational transfer of volatile chemicals in breast milk. Am Ind Hyg Assoc J 58: 425–431. Gregotti CF, Kirby Z, Manzo L, Costa LG, Faustman EM. 1994. Effects of styrene oxide on differentiation and viability of rodent embryo cultures. Toxicol Appl Pharmacol 128: 25–35. Grice HC, Munro IC, Krewski D, Blumenthal H. 1981. In utero exposure in chronic toxicity/carcinogenicity studies. Food Cosmet Toxicol 19: 373–379. Hardin BD, Bond GP, Sikov MR, Andrew FD, Beliles RP, Niemeier RW. 1981. Testing of selected workplace chemicals for teratogenic potential. Scand J Work Environ Health 7(Suppl): 66–75. Hardin BD, Niemeier RW, Sikov MR, Hackett PL. 1983. Reproductive-toxicologic assessment of the epoxides ethylene oxide, propylene oxide, butylene oxide, and styrene oxide. Scand J Work Environ Health 9: 94–102. Härkönen H, Holmberg PC. 1982. Obstetric histories of women occupationally exposed to styrene. Scand J Work Environ Health 8: 74–77. Härkönen H, Tola S, Korkala ML, Hernberg S. 1984. Congenital malformations, mortality and styrene exposure. Ann Acad Med Singapore 13(Suppl): 404–407. Health Canada. 1993. Priority substances list assessment report-styrene. Ottawa, CA: Health Canada. Hemminki K, Franssila E, Vainio H. 1980. Spontaneous abortions among female chemical workers in Finland. Int Arch Occup Environ Health 45: 123–126. Hemminki K, Lindbohm ML, Hemminki T, Vainio H. 1984. Reproductive hazards and plastics industry. Prog Clin Biol Res 141: 79–87. Hines RN, McCarver DG. 2002. The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther 300: 355–360. Holmberg PC. 1977. Central nervous system defects in two children of mothers exposed to chemicals in the reinforced plastics industry: chance or causal relation? Scand J Work Environ Health 3: 212–214. Holmberg PC. 1979. Central-nervous-system defects in children born to mothers exposed to organic solvents during pregnancy. Lancet 2: 177–179. Holmberg PC, Hernberg S, Kurppa K, Rantala K, Riala R. 1982. Oral clefts and organic solvent exposure during pregnancy. Int Arch Occup Environ Health 50: 371–376. Holmberg PC, Kurppa K, Riala R, Rantala K, Kuosma E. 1986. Solvent exposure and birth defects: an epidemiological survey. Prog Clin Biol Res 220: 179–185. Holmberg PC, Nurminen M. 1980. Congenital defects of the central nervous system and occupational factors during pregnancy. A case-referent study. Am J Ind Med 1: 167–176. HSDB. 2002. Styrene. Available at http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/∼CYHP80:1. National Library of Medicine. IARC. 2002. IARC Monographs on the evaluation of carcinogenic risks to humans. Some traditional herbal medicines, some mycotoxins, naphthalene, and styrene. Lyon: WHO. 437p. Jarry H, Gamer A, Wuttke W. 2004. Effects of 5-day styrene inhalation on serum LH and testosterone levels and on hypothalamic and striatal amino acid neurotransmitter concentrations in male rats. Inhal Toxicol 16: 209–215. Jarry H, Metten M, Gamer AO, Wuttke W. 2002. Effects of 5-day styrene inhalation on serum prolactin and dopamine levels and on hypothalamic and striatal catecholamine concentrations in male rats. Arch Toxicol 76: 657–663. Jelnes JE. 1988. Semen quality in workers producing reinforced plastic. Reprod Toxicol 2: 209–212. Johanson G, Ernstgard L, Gullstrand E, Löf A, Osterman-Golkar S, Williams CC, Sumner SC. 2000. Styrene oxide in blood, hemoglobin adducts, and urinary metabolites in human volunteers exposed to (13)C(8)-styrene vapors. Toxicol Appl Pharmacol 168: 36–49. Kankaanpää JT, Elovaara E, Hemminki K, Vainio H. 1980. The effect of maternally inhaled styrene on embryonal and foetal development in mice and Chinese hamsters. Acta Pharmacol Toxicol (Copenh) 47: 127–129. Kankaanpää; JT, Hemminki K, Vainio H. 1979. Embryotoxicity and teratogenicity of styrene and styrene oxide on chick embryos enhanced by trichloropropylene oxide. Acta Pharmacol Toxicol (Copenh) 45: 399–402. Katakura Y, Kishi R, Ikeda T, Miyake H. 1999. Effects of prenatal exposure to styrene on neurochemical levels in rat brain. Toxicol Lett 105: 239–249. Katakura Y, Kishi R, Ikeda T, Miyake H. 2001. Effects of prenatal styrene exposure on postnatal development and brain serotonin and catecholamine levels in rats. Environ Res 85: 41–47. Khanna VK, Husain R, Hanig JP, Seth PK. 1991. Increased neurobehavioral toxicity of styrene in protein-malnourished rats. Neurotoxicol Teratol 13: 153–159. Khanna VK, Husain R, Seth PK. 1994. Effect of protein malnutrition on the neurobehavioural toxicity of styrene in young rats. J Appl Toxicol 14: 351–356. Kishi R, Chen BQ, Katakura Y, Ikeda T, Miyake H. 1995. Effect of prenatal exposure to styrene on the neurobehavioral development, activity, motor coordination, and learning behavior of rats. Neurotoxicol Teratol 17: 121–130. Kishi R, Katakura Y, Ikeda T, Chen BQ, Miyake H. 1992. Neurochemical effects in rats following gestational exposure to styrene. Toxicol Lett 63: 141–146. Kishi R, Katz DS, Okui T, Ogawa H, Ikeda T, Miyake H. 1989. Placental transfer and tissue distribution of 14C-styrene. A radioautographic study in mice. Br J Ind Med 46: 376–383. Kolstad HA, Bisanti L, Roeleveld N, Baldi R, Bonde JP, Joffe M. 2000. Time to pregnancy among male workers of the reinforced plastics industry in Denmark, Italy and The Netherlands. ASCLEPIOS. Scand J Work Environ Health 26: 353–358. Kolstad HA, Bisanti L, Roeleveld N, Bonde JE, Joffe M. 1999a. Time to pregnancy for men occupationally exposed to styrene in several European reinforced plastics companies. Scand J Work Environ Health 25(Suppl): 66–69. Kolstad HA, Bonde JE, Spano M, Giwercman A, Zschiesche W, Kaae D, Roeleveld N. 1999b. Sperm chromatin structure and semen quality following occupational styrene exposure. Scand J Work Environ Health 25(Suppl): 70–73. Kolstad HA, Bonde JP, Spano M, Giwercman A, Zschiesche W, Kaae D, Larsen SB, Roeleveld N. 1999c. Change in semen quality and sperm chromatin structure following occupational styrene exposure. ASCLEPIOS. Int Arch Occup Environ Health 72: 135–141. Kurppa K, Holmberg PC, Hernberg S, Rantala K, Riala R, Nurminen T. 1983. Screening for occupational exposures and congenital malformations. Preliminary results from a nationwide case-referent study. Scand J Work Environ Health 9: 89–93. Lees PS, Stefaniak A, Emmett EA, Dalton P. 2003. Exposure assessment for study of olfactory function in workers exposed to styrene in the reinforced-plastics industry. Am J Ind Med 44: 12–23. Lemasters GK, Carson A, Samuels SJ. 1985a. Occupational styrene exposure for twelve product categories in the reinforced-plastics industry. Am Ind Hyg Assoc J 46: 434–441. Lemasters GK, Hagen A, Samuels SJ. 1985b. Reproductive outcomes in women exposed to solvents in 36 reinforced plastics companies. I. Menstrual dysfunction. J Occup Med 27: 490–494. Lemasters GK, Samuels SJ, Morrison JA, Brooks SM. 1989. Reproductive outcomes of pregnant workers employed at 36 reinforced plastics companies. II. Lowered birth weight. J Occup Med 31: 115–120. Lickly TD, Breder CV, Rainey ML. 1995. A model for estimating the daily dietary intake of a substance from food-contact articles: styrene from polystyrene food-contact polymers. Regul Toxicol Pharmacol 21: 406–417. Lindbohm ML, Hemminki K, Kyyrönen P. 1985. Spontaneous abortions among women employed in the plastics industry. Am J Ind Med 8: 579–586. Lindbohm ML, Taskinen H, Sallmén M, Hemminki K, McDonald AD, Lavoie J, Côté R, McDonald JC. 1990. Spontaneous abortions among women exposed to organic solvents. Am J Ind Med 17: 449–463. Löf A, Brohede C, Gullstrand E, Lindstrom K, Sollenberg J, Wrangskog K, Hagberg M, Hedman BK. 1993. The effectiveness of respirators measured during styrene exposure in a plastic boat factory. Int Arch Occup Environ Health 65: 29–34. Löf A, Gullstrand E, Byfält-Nordqvist M. 1983. Tissue distribution of styrene, styrene glycol and more polar styrene metabolites in the mouse. Scand J Work Environ Health 9: 419–430. Löf A, Johanson G. 1993. Dose-dependent kinetics of inhaled styrene in man. IARC Sci Publ 127: 89–99. Löf A, Lundgren E., Nordqvist MB. 1986. Kinetics of styrene in workers from a plastics industry after controlled exposure: a comparison with subjects not previously exposed. Br J Ind Med 43: 537–543. Luderer U, Tornero-Velez R, Shay T, Rappaport S, Heyer N, Echeverria D. 2004. Temporal association between serum prolactin concentration and exposure to styrene. Occup Environ Med 61: 325–333. Macaluso M, Larson R, Lynch J, Lipton S, Delzell E. 2004. Historical estimation of exposure to 1,3-butadiene, styrene, and dimethyldithiocarbamate among synthetic rubber workers. J Occup Environ Hyg 1: 371–390. McCarver DG, Hines RN. 2002. The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther 300: 361–366. McConnell EE, Swenberg JA. 1994. Review of styrene and styrene oxide long-term animal studies. Crit Rev Toxicol 24(Suppl): S49–S55. McDonald AD, Lavoie J, Côté; R, McDonald JC. 1988. Spontaneous abortion in women employed in plastics manufacture. Am J Ind Med 14: 9–14. McLaughlin J, Marliac J-M, Verrett NJ, Mutchler MK, Fitzhugh G. 1964. Toxicity of fourteen volatile chemicals as measured by the chick embryo method. Ind Hyg J 25: 282–284. McLaughlin J, Marliac J-P, Verrett MJ, Mutchler MK, Fitzhugh OG. 1963. The injection of chemicals into the yolk sac of fertile eggs prior to incubation as a toxicity test. Toxicol Appl Pharmacol 5: 760–771. Miller RR, Newhook R, Poole A. 1994. Styrene production use and human exposure. Crit Rev Toxicol 24(Suppl): S1–S10. Murray FJ, John JA, Balmer MF, Schwetz BA. 1978. Teratologic evaluation of styrene given to rats and rabbits by inhalation or by gavage. Toxicology 11: 335–343. Mutti A, Falzoi M, Romanelli A, Franchini I. 1984a. Regional alterations of brain catecholamines by styrene exposure in rabbits. Arch Toxicol 55: 173–177. Mutti A, Vescovi PP, Falzoi M, Arfini G, Valenti G, Franchini I. 1984b. Neuroendocrine effects of styrene on occupationally exposed workers. Scand J Work Environ Health 10: 225–228. NCI. 1979. Bioassay of styrene for possible carcinogenicity. Report nr NCI-CG-TR-185. Bethesda, MD: National Cancer Institute. Ninomiya R, Hirokawa Y, Yamamoto R, Masui H, Koizumi N, Kubota A. 2000. [Effects of low concentration of styrene monomer vapor on pregnancy]. Nippon Eiseigaku Zasshi 55: 547–551. NIOSH. 1981–1983. National Occupational Exposure Survey—Styrene. Available at http://www.cdc.gov/noes/noes4/70130sco.html. National Institute of Occupational Safety and Health. NIOSH. 2002. NIOSH pocket guide to chemical hazards. Available at http://www.cdc.gov/niosh/npg/npgd0571.html. National Institute of Occupational Safety and Health. NIOSH. 2004a. NIOSH HHEs for Styrene. Available at http://www.cdc.gov/niosh/hhe/. National Institute of Occupational Safety and Health. NIOSH. 2004b. RTECS—Styrene. Available at http://www.cdc.gov/niosh/rtecs/wl381378.html. National Institute of Occupational Safety and Health. NLM. 2004. Household products database. National Library of Medicine. Available at http://hpd.nlm.nih.gov/. OSHA. 1997. 29CFR1910.1000 Table Z-2. Available at http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=9993. Occupational Safety and Health Administration. Pacifici GM, Rane A. 1982. Metabolism of styrene oxide in different human fetal tissues. Drug Metab Dispos 10: 302–305. Pfäffli P, Säämänen A. 1993. The occupational scene of styrene. IARC Sci Publ 127: 15–26. Ponomarkov V, Tomatis L. 1978. Effects of long-term oral administration of styrene to mice and rats. Scand J Work Environ Health 4(Suppl): 127–135. Ramsey JC, Young JD. 1974. Pharmacokinetics of inhaled styrene in rats and humans. Scand J Work Environ Health 4(Suppl 2): 84–91. Ramsey JC, Andersen ME. 1984. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol Appl Pharmacol 73: 159–175. Rebert CS, Hall TA. 1994. The neuroepidemiology of styrene: a critical review of representative literature. Crit Rev Toxicol 24(Suppl): S57–S106. Ruder AM, Ward EM, Dong M, Okun AH, Davis-King K. 2004. Mortality patterns among workers exposed to styrene in the reinforced plastic boat building industry: an update. Am J Ind Med 45: 165–176. Sallmén M, Lindbohm ML, Anttila A, Kyyrönen P, Taskinen H, Nykyri E, Hemminki K. 1998. Time to pregnancy among the wives of men exposed to organic solvents. Occup Environ Med 55: 24–30. Salomaa S, Donner M, Norppa H. 1985. Inactivity of styrene in the mouse sperm morphology test. Toxicol Lett 24: 151–155. Sarangapani R, Teeguarden JG, Cruzan G, Clewell HJ, Andersen ME. 2002. Physiologically based pharmacokinetic modeling of styrene and styrene oxide respiratory-tract dosimetry in rodents and humans. Inhal Toxicol 14: 789–834. Scott D, Preston RJ. 1994. A re-evaluation of the cytogenetic effects of styrene. Mutat Res 318: 175–203. Sexton K, Adgate JL, Church TR, Ashley DL, Needham LL, Ramachandran G, Fredrickson AL, Ryan AD. 2004. Children's exposure to volatile organic compounds as determined by longitudinal measurements in blood. Environ Health Perspect 113: 342–349. Shanker J, Prasad AR, Datta K. 1984. Embryotoxicity of styrene and its effect on heme biosynthesis. Indian J Exp Biol 22: 167–168. Sikov MR, Cannon WC, Carr DB, Miller RA, Niemeier RW, Hardin BD. 1986. Reproductive toxicology of inhaled styrene oxide in rats and rabbits. J Appl Toxicol 6: 155–164. Speit G, Henderson L. 2005. Review of the in vivo genotoxicity tests performed with styrene. Mutat Res 589: 67–79. Srivastava S, Seth PK, Srivastava SP. 1989. Effect of styrene administration on rat testis. Arch Toxicol 63: 43–46. Srivastava S, Seth PK, Srivastava SP. 1992a. Altered activity of hepatic mixed function oxidase, cytochrome P-450 and glutathione-S-transferase by styrene in rat fetal liver. Drug Chem Toxicol 15: 233–244. Srivastava S, Seth PK, Srivastava SP. 1992b. Biochemical and morphological studies in testes of rat offspring of mothers exposed to styrene during lactation. Pharmacol Toxicol 70: 314–316. Srivastava S, Seth PK, Srivastava SP. 1992c. Effect of styrene on testicular enzymes of growing rat. Indian J Exp Biol 30: 399–401. Stoming TA, Bresnick E. 1974. Hepatic epoxide hydrase in neonatal and partially hepatectomized rats. Cancer Res 34: 2810–2813. Takao T, Nanamiya W, Nazarloo HP, Asaba K, Hashimoto K. 2000. Possible reproductive toxicity of styrene in peripubertal male mice. Endocr J 47: 343–347. Tang W, Hemm I, Eisenbrand G. 2000. Estimation of human exposure to styrene and ethylbenzene. Toxicology 144: 39–50. Taskinen H, Anttila A, Lindbohm ML, Sallmén M, Hemminki T. 1989. Spontaneous abortions and congenital malformations among the wives of men occupationally exposed to organic solvents. Scand J Work Environ Health 15: 345–352. USEPA. 2002. Toxics Release Inventory data for styrene. Available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?TRI. U.S. Environmental Protection Agency. USEPA. 2004. Drinking water standards and health advisories. Washington, DC: United States Environmental Protection Agency. Vainio H, Hemminki K, Elovaara E. 1977. Toxicity of styrene and styrene oxide on chick embryos. Toxicology 8: 319–325. Welp E, Partanen T, Kogevinas M, Andersen A, Bellander T, Biocca M, Coggon D, Fontana V, Kolstad H, Lundberg I, Lynge E, Spence A, Ferro G, Boffetta P, Saracci R. 1996. Exposure to styrene and mortality from nonmalignant diseases of the genitourinary system. Scand J Work Environ Health 22: 223–226. Wigaeus E, Löf A, Bjurström R, Nordqvist MB. 1983. Exposure to styrene. Uptake, distribution, metabolism, and elimination in man. Scand J Work Environ Health 9: 479–488. Withey JR, Karpinski K. 1985. Fetal distribution of styrene in rats after vapor phase exposures. Biol Res Pregnancy Perinatol 6: 59–64. Zaidi NF, Agrawal AK, Srivastava SP, Seth PK. 1985. Effect of gestational and neonatal styrene exposure on dopamine receptors. Neurobehav Toxicol Teratol 7: 23–28. Citing Literature Volume77, Issue2April 2006Pages 110-193 ReferencesRelatedInformation
Referência(s)